Trial intelligence / Profile preview

Insulin Aspart PK/PD in T2DM

NCT01510093Phase 2Completed

Sponsor
Aarhus University Hospital
Start
May 2012
Primary completion
Dec 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Aarhus University Hospital. Started May 2012; status: completed.

02

Drugs

insulin aspart
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01510093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01510093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call